Cook, R. R. https://orcid.org/0000-0001-8754-995X
Foot, C.
Arah, O. A.
Humphreys, K.
Rudolph, K. E.
Luo, S. X.
Tsui, J. I.
Levander, X. A.
Korthuis, P. T.
Funding for this research was provided by:
National Drug Abuse Treatment Clinical Trials Network (UG1DA013035)
National Institute on Drug Abuse (K01DA055130, UG3DA044829/UH3DA044829, UG3DA044798/UH3DA044798, UG3DA044830/UH3DA044830, UG3DA044823/UH3DA044823, UH3DA044822/UH3DA044822, UG3DA044831/UH3DA044831, UG3DA044825, UG3DA044826/UH3DA044826, U24DA044801, UL1TR002369)
Agency for Healthcare Research and Quality (K12HS026370)
Article History
Received: 29 August 2022
Accepted: 1 February 2023
First Online: 14 February 2023
Declarations
:
: All included studies were conducted with ethical approval and all included participants provided informed consent prior to participation. CHOICES was approved by the Advarra Institutional Review Board (IRB00000971), with participating sites deferring to its regulatory role, while each site in X:BOT and the ROI received local IRB approval prior to trial initiation. The NSDUH and TEDS are collected by the U.S. Substance Abuse and Mental Health Services Administration under federal privacy and confidentiality laws and regulations ().
: Not applicable.
: The authors declare that they have no competing interests.